Patients treated at MSK have access to a number of CAR T-based clinical trials. To identify available trials, search the box below.
19-085 (Dr. Geyer) A Phase I/II Study of CAR T-Cell Therapy to Treat Persistent or Recurrent Chronic Lymphocytic Leukemia
Lung Cancer/Breast Cancer/Mesothelioma
15-007 (Dr. Adusumilli) A Phase I Study of Immunotherapy with Genetically Engineered T Cells (CAR T Cells) to Treat Mesothelioma and Malignant Pleural Disease from Lung and Breast Cancers
15-014 (Dr. O’Cearbhaill) A Phase I Study of Immunotherapy with Genetically Modified T Cells plus Cyclophosphamide to Treat Recurrent High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
19-392 (Dr. Mailankody) A Phase I Study of ALLO-647 with ALLO-715 CAR T-Cell Therapy in People with Recurrent or Persistent Multiple Myeloma